Loading drugs…
Loading drugs…
Drugs
One entity per molecule (INN preferred); brand names and development codes are aliases. Approvals are always shown with jurisdiction and indication.
819 drugs
| Drug | Kind | Mechanism | Approvals | Evidence items | Trials | Identifiers |
|---|---|---|---|---|---|---|
| Patritumab | Monoclonal Antibody | Receptor tyrosine-protein kinase erbB-3 inhibitor | 0 | 1 | 6 | C78853 · CHEMBL2109406 |
| Patritumab Deruxtecan | Adc | Receptor tyrosine-protein kinase erbB-3 binding agent; DNA topoisomerase I inhibitor | 0 | 1 | 20 | C136987 · CHEMBL4594611 |
| PCV Regimen | — | — | 0 | 1 | 2 | C63491 |
| PD-180970 | — | — | 0 | 1 | 0 | — |
| PD-L1 Inhibitor | — | — | 0 | 1 | 5 | C191689 |
| Pegargiminase | Other | L-arginine hydrolytic enzyme | 0 | 1 | 33 | C91702 · CHEMBL3137346 |
| Pembrolizumab/Pemetrexed Regimen | — | — | 0 | 1 | 0 | C157398 |
| Pemrametostat | Small Molecule | Protein arginine N-methyltransferase 5 inhibitor | 0 | 1 | 3 | C142177 · CHEMBL4466233 |
| Pertuzumab/Trastuzumab Regimen | — | — | 0 | 1 | 5 | C138042 |
| PHA-665752 | Small Molecule | — | 0 | 1 | 0 | CHEMBL450786 |
| Picoplatin | Small Molecule | DNA cross-linking agent | 0 | 1 | 7 | C48416 · CHEMBL3544907 |
| Pictilisib Bismesylate | — | — | 0 | 1 | 0 | C82380 |
| Pilaralisib | Small Molecule | PI3-kinase class I inhibitor | 0 | 1 | 13 | C71705 · CHEMBL3360203 |
| Pixantrone | Small Molecule | DNA cross-linking agent | 0 | 1 | 6 | C26663 · CHEMBL167731 |
| Platinum Doublet | — | — | 0 | 1 | 5 | C162261 |
| PLX8725 | — | — | 0 | 1 | 0 | — |
| Porcupine Inhibitor WNT974 | — | — | 0 | 1 | 3 | C116860 |
| PSI | — | — | 0 | 1 | 0 | — |
| Pyridostatin | Small Molecule | — | 0 | 1 | 0 | CHEMBL2349416 |
| Pyrimidine Antagonist | — | — | 0 | 1 | 0 | C1557 |
| Pyrotinib | Small Molecule | Epidermal growth factor receptor erbB1 inhibitor; Receptor protein-tyrosine kinase erbB-2 inhibitor | 0 | 1 | 107 | C111895 · CHEMBL3647420 |
| Quisinostat | Small Molecule | Histone deacetylase inhibitor | 0 | 1 | 7 | C77912 · CHEMBL2105763 |
| Radioactive Iodine | — | — | 0 | 1 | 2 | C2462 |
| Rebastinib | Small Molecule | Tyrosine-protein kinase ABL inhibitor | 0 | 1 | 4 | C152162 · CHEMBL1738757 |
| RG5 | — | — | 0 | 1 | 0 | — |
| Rilotumumab | Monoclonal Antibody | Hepatocyte growth factor inhibitor | 0 | 1 | 13 | C67079 · CHEMBL1743063 |
| Rindopepimut | — | Epidermal growth factor receptor erbB1 vaccine antigen | 0 | 1 | 2 | C69076 · CHEMBL2107863 |
| RMC-4550 | — | — | 0 | 1 | 0 | — |
| Safusidenib | Small Molecule | Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor | 0 | 1 | 6 | C148134 · CHEMBL4651002 |
| Samotolisib | Small Molecule | Serine/threonine-protein kinase mTOR inhibitor; PI3-kinase class I inhibitor | 0 | 1 | 14 | C121817 · CHEMBL4297181 |
| SB202190 | — | — | 0 | 1 | 0 | — |
| SCH772984 | Small Molecule | — | 0 | 1 | 0 | CHEMBL3590107 |
| Seribantumab | Monoclonal Antibody | Receptor tyrosine-protein kinase erbB-3 antagonist; Receptor tyrosine-protein kinase erbB-3 inhibitor | 0 | 1 | 13 | C78859 · CHEMBL3545071 |
| SGK1-Inh | — | — | 0 | 1 | 0 | — |
| SHP2 Inhibitor | — | — | 0 | 1 | 0 | C185612 |
| Stattic | — | — | 0 | 1 | 0 | — |
| Staurosporine | Small Molecule | — | 0 | 1 | 0 | C1237 · CHEMBL388978 |
| TAK-788 | Small Molecule | Epidermal growth factor receptor erbB1 inhibitor | 0 | 1 | 4 | CHEMBL4650319 |
| Tamibarotene | Small Molecule | Retinoic acid receptor beta agonist; Retinoic acid receptor alpha agonist | 0 | 1 | 8 | C71025 · CHEMBL25202 |
| Tarloxotinib | Small Molecule | Epidermal growth factor receptor inhibitor | 0 | 1 | 2 | C101523 · CHEMBL4297661 |
| Taxol | — | — | 0 | 1 | 23 | — |
| Tgx 221 | — | — | 0 | 1 | 0 | — |
| TGX221 | — | — | 0 | 1 | 0 | — |
| Therapeutic Glucocorticoid | — | — | 0 | 1 | 6 | C521 |
| Tizaterkib | Small Molecule | — | 0 | 1 | 1 | C176765 · CHEMBL4482864 |
| Tozasertib | Small Molecule | Serine/threonine-protein kinase Aurora inhibitor | 0 | 1 | 1 | C98053 · CHEMBL572878 |
| Tranilast | Small Molecule | — | 0 | 1 | 2 | C152712 · CHEMBL415324 |
| Transplantation | — | — | 0 | 1 | 0 | C15342 |
| Trastuzumab Deruxtecan Regimen | — | — | 0 | 1 | 1 | C173972 |
| Trastuzumab Emtansine Regimen | — | — | 0 | 1 | 0 | C202670 |